There are several human tissues that have been successfully or partially induced to regenerate. Many fall under the topic of
regenerative medicine, which includes the methods and research conducted with the aim of regenerating the organs and tissues of humans as a result of injury. The major strategies of regenerative medicine include dedifferentiating injury site cells, transplanting stem cells, implanting lab-grown tissues and organs, and implanting bioartificial tissues.
Bladder In 1999, the bladder was the first regenerated organ to be given to seven patients; as of 2014, these regenerated bladders are still functioning inside the beneficiaries.
Fat In 1949, purified insulin was shown to regenerate fat in diabetics with
lipoatrophy. Scientists also identified
bone morphogenetic protein (BMP) signalling as important for myofibroblasts transforming into adipocytes for the purpose of skin and fat regeneration. In addition, during a typical
myocardial infarction or heart attack, an estimated one billion cardiac cells are lost. The scarring that results is then responsible for greatly increasing the risk of life-threatening abnormal heart rhythms or
arrhythmias. Therefore, the ability to naturally regenerate the heart would have an enormous impact on modern healthcare. However, while several animals can regenerate heart damage (e.g. the
axolotl), mammalian
cardiomyocytes (heart muscle cells) cannot proliferate (multiply) and heart damage causes scarring and
fibrosis. Despite the earlier belief that human cardiomyocytes are not generated later in life, a recent study has found that this is not the case. This study took advantage of the
nuclear bomb testing and other
radioactive sources during the
Atomic Age which introduced
carbon-14 into the
atmosphere (essentially all of which had
decayed up to that point in
Earth's history) and therefore into the cells of biologically active inhabitants. They extracted DNA from the myocardium of these research subjects and found that cardiomyocytes do in fact renew at a slowing rate of 1% per year from the age of 25, to 0.45% per year at the age of 75 by comparing the presence of carbon-14 with the stable and abundant
carbon-12. Further research has been conducted that supports the potential for human cardiac regeneration. Inhibition of
p38 MAP kinase was found to induce mitosis in adult mammalian cardiomyocytes, while treatment with
FGF1 and p38 MAP kinase inhibitors was found to regenerate the heart, reduce scarring, and improve cardiac function in rats with cardiac injury. One of the most promising sources of heart regeneration is the use of stem cells. It was demonstrated in mice that there is a resident population of stem cells or cardiac progenitors in the adult heart – this population of stem cells was shown to be reprogrammed to differentiate into cardiomyocytes that replaced those lost during a heart tissue death. In humans specifically, a "cardiac mesenchymal feeder layer" was found in the myocardium that renewed the cells with progenitors that differentiated into mature cardiac cells. What these studies show is that the human heart contains stem cells that could potentially be induced into regenerating the heart when needed, rather than just being used to replace expended cells. Loss of the myocardium due to disease often leads to heart failure; therefore, it would be useful to be able to take cells from elsewhere in the heart to replenish those lost. This was achieved in 2010 when mature cardiac
fibroblasts were reprogrammed directly into cardiomyocyte-like cells. This was done using three
transcription factors:
GATA4,
Mef2c, and
Tbx5. Cardiac fibroblasts make up more than half of all heart cells and are usually not able to conduct contractions (are not cardiogenic), but those reprogrammed were able to contract spontaneously. These sheets were still found to be present four weeks later. In 2021, researchers demonstrated a switchable iPSCs-
reprogramming-based approach for regeneration of damaged heart without tumor-formation in mice. In April 2019, researchers
3D printed a prototype human heart the size of a rabbit's heart. Worse still, due to increasing smoking rates and the aging populations in many countries, the number of deaths as a result of COPD and other chronic
lung diseases is predicted to continue increasing. Therefore, developments in the lung's capacity for regeneration is in high demand. It has been shown that bone marrow-derived cells could be the source of progenitor cells of multiple cell lineages, and a 2004 study suggested that one of these cell types was involved in lung regeneration. Therefore, a potential source of cells for lung regeneration has been found; however, due to advances in inducing stem cells and directing their differentiation, major progress in lung regeneration has consistently featured the use of patient-derived iPSCs and bioscaffolds. The
extracellular matrix is the key to generating entire organs in vitro. It was found that by carefully removing the cells of an entire lung, a "footprint" is left behind that can guide cellular adhesion and differentiation if a population of lung epithelial cells and
chondrocytes are added. This has serious applications in regenerative medicine, particularly as a 2012 study successfully purified a population of lung progenitor cells that were derived from embryonic stem cells. These can then be used to re-cellularise a three-dimensional lung tissue scaffold. A 2010 investigation used the ECM scaffold to produce entire lungs in vitro to be transplanted into living rats. These successfully enabled
gas exchange but for short time intervals only.
Cystic fibrosis is another disease of the lungs, which is highly fatal and genetically linked to a mutation in the
CFTR gene. Through growing patient-specific lung epithelium in vitro, lung tissue expressing the cystic fibrosis phenotype has been achieved. This is so that modelling and drug testing of the disease pathology can be carried out with the hope of regenerative medical applications.
Penis Penises have been successfully regenerated in the lab. The nerves in the spine are a tissue that requires a stem cell population to regenerate. In 2012, a Polish fireman
Darek Fidyka, with
paraplegia of the spinal cord, underwent a procedure, which involved extracting
olfactory ensheathing cells (OECs) from Fidyka's
olfactory bulbs, and injecting these stem cells, in vivo, into the site of the previous injury. Fidyka eventually gained feeling, movement and sensation in his limbs, especially on the side where the stem cells were injected; he also reported gaining sexual function. Fidyka can now drive and can now walk some distance aided by a frame. He is believed to be the first person in the world to recover sensory function from a complete severing of the spinal nerves.
Thymus The thymus gland is one of the first organs to degenerate in normal healthy individuals. Researchers from the
University of Edinburgh have succeeded in regenerating a living organ that closely resembles a juvenile
thymus in terms of structure and gene expression profile.
Vagina Between the years 2005 and 2008, four women with
vaginal hypoplasia due to
Müllerian agenesis were given regenerated vaginas. Up to eight years after the transplants, all organs have normal function and structure. ==See also==